Metformin ameliorates ferroptosis in cardiac ischemia and reperfusion by reducing NOX4 expression via promoting AMPKα

References

• Benjanuwattra J, Apaijai N, Chunchai T, Kerdphoo S, Jaiwongkam T, Arunsak B, Wongsuchai S, Chattipakorn N, Chattipakorn SC. 2020. Metformin preferentially provides neuroprotection following cardiac ischemia/reperfusion in non-diabetic rats. Biochim Biophys Acta Mol Basis Dis. 1866(10):165893.
   PubMed Web of Science ®Google Scholar
• Chen X, Li X, Zhang W, He J, Xu B, Lei B, Wang Z, Cates C, Rousselle T, Li J. 2018. Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway. Metabolism. 83:256–270.
   PubMed Web of Science ®Google Scholar
• Denorme F, Manne BK, Portier I, Eustes AS, Kosaka Y, Kile BT, Rondina MT, Campbell RA. 2020. Platelet necrosis mediates ischemic stroke outcome in mice. Blood. 135(6):429–440.
   PubMed Web of Science ®Google Scholar
• Ding R, Wu W, Sun Z, Li Z. 2020. AMP-activated protein kinase: an attractive therapeutic target for ischemia–reperfusion injury. Eur J Pharmacol. 888:173484.
   PubMed Web of Science ®Google Scholar
• Ge X, Meng Q, Wei L, Liu J, Li M, Liang X, Lin F, Zhang Y, Li Y, Liu Z, et al. 2021. Myocardial ischemia–reperfusion induced cardiac extracellular vesicles harbour proinflammatory features and aggravate heart injury. Extracell Vesicles. 10:e12072.
   Google Scholar
• Hsu S-K, Cheng K-C, Mgbeahuruike MO, Lin Y-H, Wu C-Y, Wang H-MD, Yen C-H, Chiu C-C, Sheu S-J. 2021. New insight into the effects of metformin on diabetic retinopathy, aging and cancer: nonapoptotic cell death, immunosuppression, and effects beyond the AMPK pathway. Int J Mol Sci. 22(17):9453.
   PubMed Web of Science ®Google Scholar
• Lahnwong S, Palee S, Apaijai N, Sriwichaiin S, Kerdphoo S, Jaiwongkam T, Chattipakorn SC, Chattipakorn N. 2020. Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury. Cardiovasc Diabetol. 19(1):91.
   PubMed Web of Science ®Google Scholar
• Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, Tyagi S, Ma L, Westbrook TF, Steinberg GR, et al. 2020. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 22(2):225–234.
   PubMed Web of Science ®Google Scholar
• Li N, Wang W, Zhou H, Wu Q, Duan M, Liu C, Wu H, Deng W, Shen D, Tang Q. 2020. Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury. Free Radic Biol Med. 160:303–318.
   PubMed Web of Science ®Google Scholar
• Li T, Tan Y, Ouyang S, He J, Liu L. 2022. Resveratrol protects against myocardial ischemia–reperfusion injury via attenuating ferroptosis. Gene. 808:145968.
   PubMed Web of Science ®Google Scholar
• Li W, Jin S, Hao J, Shi Y, Li W, Jiang L. 2021. Metformin attenuates ischemia/reperfusion-induced apoptosis of cardiac cells by downregulation of p53/microRNA-34a via activation of SIRT1. Can J Physiol Pharmacol. 99(9):875–884.
   PubMed Web of Science ®Google Scholar
• Liao S, Apaijai N, Luo Y, Wu J, Chunchai T, Singhanat K, Arunsak B, Benjanuwattra J, Chattipakorn N, Chattipakorn SC. 2021. Cell death inhibitors protect against brain damage caused by cardiac ischemia/reperfusion injury. Cell Death Discov. 7(1):312.
   PubMed Web of Science ®Google Scholar
• Liu X, Qi K, Gong Y, Long X, Zhu S, Lu F, Lin K, Xu J. 2021. Ferulic acid alleviates myocardial ischemia reperfusion injury via upregulating AMPKα2 expression-mediated ferroptosis depression. J Cardiovasc Pharmacol. 79(4):489–500.
   PubMed Web of Science ®Google Scholar
• Luo T, Zeng X, Yang W, Zhang Y. 2019. Treatment with metformin prevents myocardial ischemia–reperfusion injury via STEAP4 signaling pathway. Anatol J Cardiol. 21(5):261–271.
   PubMed Web of Science ®Google Scholar
• Ma S, Sun L, Wu W, Wu J, Sun Z, Ren J. 2020. USP22 protects against myocardial ischemia–reperfusion injury via the SIRT1-p53/SLC7A11-dependent inhibition of ferroptosis-induced cardiomyocyte death. Front Physiol. 11:551318.
   PubMed Web of Science ®Google Scholar
• Park MW, Cha HW, Kim J, Kim JH, Yang H, Yoon S, Boonpraman N, Yi SS, Yoo ID, Moon JS. 2021. NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer’s diseases. Redox Biol. 41:101947.
   PubMed Web of Science ®Google Scholar
• Shan X, Lv Z-Y, Yin M-J, Chen J, Wang J, Wu Q-N. 2021. The protective effect of cyanidin-3-glucoside on myocardial ischemia–reperfusion injury through ferroptosis. Oxid Med Cell Longev. 2021:8880141.
   PubMed Web of Science ®Google Scholar
• Shi Y, Hou SA. 2021. Protective effects of metformin against myocardial ischemia–reperfusion injury via AMPK‑dependent suppression of NOX4. Mol Med Rep. 24(4):712.
   PubMed Web of Science ®Google Scholar
• Stamenkovic A, O'Hara KA, Nelson DC, Maddaford TG, Edel AL, Maddaford G, Dibrov E, Aghanoori M, Kirshenbaum LA, Fernyhough P, et al. 2021. Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia–reperfusion injury. Am J Physiol Heart Circ Physiol. 320(3):H1170–H1184.
   PubMed Web of Science ®Google Scholar
• Sun L, Wang H, Yu S, Zhang L, Jiang J, Zhou Q. 2021. Herceptin induces ferroptosis and mitochondrial dysfunction in H9c2 cells. Int J Mol Med. 49(2):17.
   PubMed Web of Science ®Google Scholar
• Szekeres FLM, Walum E, Wikström P, Arner A. 2021. A small molecule inhibitor of Nox2 and Nox4 improves contractile function after ischemia–reperfusion in the mouse heart. Sci Rep. 11(1):11970.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou H. 2020. Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia–reperfusion injury. Acta Pharm Sin B. 10(10):1866–1879.
   PubMed Web of Science ®Google Scholar
• Wu X, Li Y, Zhang S, Zhou X. 2021. Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics. 11(7):3052–3059.
   PubMed Web of Science ®Google Scholar
• Xu S, Wu B, Zhong B, Lin L, Ding Y, Jin X, Huang Z, Lin M, Wu H, Xu D. 2021. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2)/system xc-/glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered. 12(2):10924–10934.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhou Y, Xie S, Wang J, Li Z, Chen L, Mao M, Chen C, Huang A, Chen Y. 2021. Metformin induces ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. Exp Clin Cancer Res. 40:206.
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang L, Shi X, Yang L, Hua F, Ma J, Zhu W, Liu X, Xuan R, Shen Y, et al. 2020. Metformin protects against myocardial ischemia–reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway. Aging. 12(23):24270–24287.
   PubMedGoogle Scholar
• Zhao W-K, Zhou Y, Xu T-T, Wu Q. 2021. Ferroptosis: opportunities and challenges in myocardial ischemia–reperfusion injury. Oxid Med Cell Longev. 2021:9929687.
   PubMed Web of Science ®Google Scholar